| 351 |
New 1, 3, 4‐oxadiazoles linked with the 1, 2, 3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase |
قسم الكيمياء العضوية الصيدلية |
2022 |
| 352 |
New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization |
قسم الكيمياء العضوية الصيدلية |
2022 |
| 353 |
New 1,2,4-oxadiazole/pyrrolidine hybrids as Topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity |
|
2022 |
| 354 |
New 1,3,4-Oxadiazole-Chalcone/Benzimidazole Hybrids as Potent Anti-proliferative Agents |
قسم الكيمياء العضوية الصيدلية |
2022 |
| 355 |
New Cell Cycle Checkpoint Pathways Regulators with 2-Oxo-indoline Scaffold as Potential Anticancer Agents: Design, Synthesis, Biological Activities and In Silico Studies |
قسم الكيمياء الدوائية |
2022 |
| 356 |
New Insights into the Structural Requirements of Isatin-Derived Pro-Apoptotic Agents against Acute Myeloid Leukemia |
قسم الكيمياء الدوائية |
2022 |
| 357 |
New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition |
قسم الكيمياء العضوية الصيدلية |
2022 |
| 358 |
Novel Azine Linked Hybrids of 2-indolinone and Thiazolodinone Scaffolds as CDK2 Inhibitors with Potential Anticancer Activity: In Silico Design, Synthesis, Biological, Molecular Dynamics and Binding Free Energy Studies |
قسم الكيمياء الدوائية |
2022 |
| 359 |
Novel indazole derivatives as potent apoptotic antiproliferative agents by multi-targeted mechanism: Synthesis and biological evaluation |
قسم الكيمياء العضوية الصيدلية |
2022 |
| 360 |
Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway |
قسم الكيمياء العضوية الصيدلية |
2022 |
